相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection
Shih-Hao Young et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2020)
Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study
Yen-Hsiang Liao et al.
BMC GASTROENTEROLOGY (2020)
Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case-control study
Yi Shen et al.
CANCER CAUSES & CONTROL (2020)
Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants
Shuijing Wang et al.
PHARMACOLOGICAL RESEARCH (2020)
Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality
Tracey G. Simon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
Teng-Yu Lee et al.
JAMA INTERNAL MEDICINE (2019)
496 – Aspirin Use is Associated with Reduced Risk for Incident Hepatocellular Carcinoma in Patients with Chronic Viral Hepatitis: Results from a Nationwide Population
Tracey G. Simon et al.
GASTROENTEROLOGY (2019)
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
Mohsen Malehmir et al.
NATURE MEDICINE (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Effect of low-dose aspirin administration on long-term survival of cirrhotic patients after splenectomy: A retrospective single-center study
Zhao-Qing Du et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Long-term use of low-dose aspirin for cancer prevention: A 10-year population cohort study in Hong Kong
Kelvin K. F. Tsoi et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Association of Long-term Use of Low-Dose Aspirin as Chemoprevention With Risk of Lung Cancer
Shinhee Ye et al.
JAMA NETWORK OPEN (2019)
Aspirin Use and Risk of Hepatocellular Carcinoma in a National Cohort Study of Korean Adults
In Cheol Hwang et al.
SCIENTIFIC REPORTS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Association Between Aspirin Use and Risk of Hepatocellular Carcinoma
Tracey G. Simon et al.
JAMA ONCOLOGY (2018)
Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study
Gyuri Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Antiplatelet Therapy and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Antiviral Treatment
Minjong Lee et al.
HEPATOLOGY (2017)
Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice
H. Chen et al.
ONCOGENE (2017)
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015
Tomi Akinyemiju et al.
JAMA ONCOLOGY (2017)
Associations of NSAID and paracetamol use with risk of primary liver cancer in the Clinical Practice Research Datalink
Baiyu Yang et al.
CANCER EPIDEMIOLOGY (2016)
Risk of prostate cancer in low-dose aspirin users: A retrospective cohort study
F. Lapi et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer
Yin Cao et al.
JAMA ONCOLOGY (2016)
Nonsteroidal Anti-inflammatory Drugs Are Associated With Reduced Risk of Early Hepatocellular Carcinoma Recurrence After Curative Liver Resection A Nationwide Cohort Study
Chun-Chieh Yeh et al.
ANNALS OF SURGERY (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Chronic hepatitis B: role of anti-platelet therapy in inflammation control
Roberto Aiolfi et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Statin and aspirin for prevention of hepatocellular carcinoma: What are the levels of evidence?
Fabrice Carrat
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2014)
Converting an odds ratio to a range of plausible relative risks for better communication of research findings
Robert L. Grant
BMJ-BRITISH MEDICAL JOURNAL (2014)
Aspirin overcomes Navitoclax-resistance in hepatocellular carcinoma cells through suppression of Mcl-1
Gongquan Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Aspirin enhances IFN-α-induced growth inhibition and apoptosis of hepatocellular carcinoma via JAK1/STAT1 pathway
T. Li et al.
CANCER GENE THERAPY (2013)
Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer-a systematic review and meta-analysis
Charalampos Siristatidis et al.
HUMAN REPRODUCTION UPDATE (2013)
Anti-platelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma
Giovanni Sitia et al.
JOURNAL OF HEPATOLOGY (2013)
Hepatocellular Carcinoma Confirmation, Treatment, and Survival in Surveillance, Epidemiology, and End Results Registries, 1992-2008
Sean F. Altekruse et al.
HEPATOLOGY (2012)
Aspirin induces apoptosis in vitro and inhibits tumor growth of human hepatocellular carcinoma cells in a nude mouse xenograft model
Mohammad Akbar Hossain et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Daily Aspirin Use and Cancer Mortality in a Large US Cohort
Eric J. Jacobs et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Nonsteroidal Anti-inflammatory Drug Use, Chronic Liver Disease, and Hepatocellular Carcinoma
Vikrant V. Sahasrabuddhe et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Platelets harness the immune response to drive liver cancer
Mala K. Maini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B
Giovanni Sitia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Statin Use and the Risk of Liver Cancer: A Population-Based Case-Control Study
Hui-Fen Chiu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
The Global Epidemiology of Hepatocellular Carcinoma: Present and Future
Katherine A. McGlynn et al.
CLINICS IN LIVER DISEASE (2011)
Acetylsalicylic acid-induced oxidative stress, cell cycle arrest, apoptosis and mitochondrial dysfunction in human hepatoma HepG2 cells
Haider Raza et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Platelets and the immune continuum
John W. Semple et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers
Matthew M. Yeh et al.
MODERN PATHOLOGY (2010)
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2
Andrew T. Chan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Drug therapy -: Low-dose aspirin for the prevention of atherothrombosis
C Patrono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Platelets mediate cytotoxic T lymphocyte-induced liver damage
M Iannacone et al.
NATURE MEDICINE (2005)
Low-dose aspirin in the primary prevention of cancer the women's health study: A randomized controlled trial
NR Cook et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: implication of HBx in upregulation of COX-2
ASL Cheng et al.
MODERN PATHOLOGY (2004)
Aspirin and clopidogrel - Efficacy, safety, and the issue of drug resistance
M Cattaneo
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through AKT activation: Evidence for AKT inhibition in celecoxib-induced apoptosis
J Leng et al.
HEPATOLOGY (2003)
Proapoptotic and anti proliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells
MA Kern et al.
HEPATOLOGY (2002)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death
F Degos et al.
GUT (2000)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Cyclooxygenase-2 expression in human pancreatic adenocarcinomas
MT Yip-Schneider et al.
CARCINOGENESIS (2000)
分享论文
